The human placenta in gestational diabetes mellitus: The insulin and cytokine network

Diabetes Care

Volumn 30, Issue SUPPL. 2, 2007, Pages

  Desoye, Gernot ^a   Hauguel De Mouzon, Sylvie ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INSULIN RECEPTOR; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE RELEASE; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA PERFUSION; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST;

CYTOKINES; DIABETES, GESTATIONAL; FEMALE; HUMANS; PLACENTA; PREGNANCY; RECEPTOR, INSULIN;

EID: 34447118714     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-s203     Document Type: Article

References (74)

1. Desoye G, Hauguel de Mouzon S, Shafrir E: The placenta in diabetic pregnancy. In Textbook of Diabetes and Pregnancy. Hod M, Jovanovic L, DiRenzo G-C, deLeiva A, Langer O, Eds. London, Dunitz M, 2003, p. 126-147
2. Desoye G, Myatt L: The placenta. In Diabetes in Women: Adolescence, Pregnancy, and Menopause. 3rd ed. Reece EA, Coustan DR, Gabbe SG, Eds. Philadelphia, Lippincott Williams & Wilkins, 2004, p. 147-157
3. Desoye G, Shafrir E: The human placenta in diabetic pregnancy. Diabetes Reviews 4:70-89, 1996
4. Kaufmann P, Mayhew TM, Charnock-Jones DS: Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25:114-126, 2004
5. Mayhew TM: Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 23:742-750, 2002
6. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S: Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52:2951-2958, 2003
7. Hahn T, Barth S, Weiss U, Mosgoeller W, Desoye G: Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development? FASEB J 12:1221-1231, 1998
8. Hahn T, Hahn D, Blaschitz A, Korgun ET, Desoye G, Dohr G: Hyperglycaemiainduced subcellular redistribution of GLUT1 glucose transporters in cultured human term placental trophoblast cells. Diabetologia 43:173-180, 2000
9. Illsley NP, Sellers MC, Wright RL: Glycaemic regulation of glucose transporter expression and activity in the human placenta. Placenta 19:517-524, 1998
10. Osmond DT, King RG, Brennecke SP, Gude NM: Placental glucose transport and utilisation is altered at term in insulin-treated, gestational-diabetic patients. Diabetologia 44:1133-1139, 2001
11. Osmond DT, Nolan CJ, King RG, Brennecke SP, Gude NM: Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation. Diabetologia 43:576-582, 2000
12. Hauguel S, Desmaizieres V, Challier JC: Glucose uptake, utilization, and transfer by the human placenta as functions of maternal glucose concentration. Pediatr Res 20:269-273, 1986
13. Kuruvilla AG, D'Souza SW, Glazier JD, Mahendran D, Maresh MJ, Sibley CP: Altered activity of the system A amino acid transporter in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women. J Clin Invest 94:689-695, 1994
14. Desoye G, Hartmann M, Blaschitz A, Dohr G, Hahn T, Kohnen G, Kaufmann P: Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta: immunohistochemical evidence for developmental changes in distribution pattern. Histochemistry 101:277-285, 1994
15. Desoye G, Hartmann M, Jones CJ, Wolf HJ, Kohnen G, Kosanke G, Kaufmann P: Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech 38:63-75, 1997
16. Hiden U, Maier A, Bilban M, Ghaffari-Tabrizi N, Wadsack C, Lang I, Dohr G, Desoye G: Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy. Diabetologia 49:123-131, 2006
17. Desoye G, Hofmann HH, Weiss PA: Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 35:45-55, 1992
18. Hiden U, Maier A, Ghaffari-Tabrizi N, Wadsack C, Desoye G: Differential insulin receptor expression causes differential insulin signalling in the two interfaces of the human placenta (Abstract). Placenta 26:A.9, 2005
19. Mandl M, Haas J, Bischof P, Nohammer G, Desoye G: Serum-dependent effects of IGF-I and insulin on proliferation and invasion of human first trimester trophoblast cell models. Histochem Cell Biol 117:391-399, 2002
20. Siddiqi TA, Miodovnik M, Mimouni F, Clark EA, Khoury JC, Tsang RC: Biphasic intrauterine growth in insulin-dependent diabetic pregnancies. J Am Coll Nutr 8:225-234, 1989
21. Robinson J, Canavan JP, el Haj AJ, Goldspink DF: Maternal diabetes in rats. I. Effects on placental growth and protein turnover. Diabetes 37:1665-1670, 1988
22. Desoye G, Korgun ET, Ghaffari-Tabrizi N, Cetin I, Hahn T: Selective upregulation of placental glycogenin-2 in gestational diabetes is independent of hyperglycemia or hyperinsulinemia. J Soc Gyn Invest 11 (Suppl.):299A, 2004
23. Hahn D, Blaschitz A, Korgun ET, Lang I, Desoye G, Skofitsch G, Dohr G: From maternal glucose to fetal glycogen: expression of key regulators in the human placenta. Mol Hum Reprod 7:1173-1178, 2001
24. Xing AY, Challier JC, Lepercq J, Cauzac M, Charron MJ, Girard J, Hauguel-de Mouzon S: Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. J Clin Endocrinol Metab 83:4097-4101, 1998
25. Schneider H, Reiber W, Sager R, Malek A: Asymmetrical transport of glucose across the in vitro perfused human placenta. Placenta 24:27-33, 2003
26. Thomas CR, Eriksson GL, Eriksson UJ: Effects of maternal diabetes on placental transfer of glucose in rats. Diabetes 39:276-282, 1990
27. Goltzsch W, Bittner R, Bohme HJ, Hofmann E: Effect of prenatal insulin and glucagon injection on the glycogen content of rat placenta and fetal liver. Biomed Biochim Acta 46:619-622, 1987
28. Desoye G, Korgun ET, Ghaffari-Tabrizi N, Hahn T: Is fetal macrosomia in adequately controlled diabetic women the result of a placental defect? A hypothesis. J Matern Fetal Neonatal Med 11:258-261, 2002
29. Story CJ, Roberts AP, Ryall RG: Borderline maintenance of erythrocyte 2,3-diphosphoglycerate concentrations in normoxic type 1 (insulin dependent) diabetic subjects. Clin Sci (Lond) 70:127-129, 1986
30. al-Okail MS, al-Attas OS: Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients. Endocr J 41:355-360, 1994
31. Yang WC, Su TH, Yang YC, Chang SC, Chen CY, Chen CP: Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 26:780-788, 2005
32. Fadda GM, D'Antona D, Ambrosini G, Cherchi PL, Nardelli GB, Capobianco G, Dessole S: Placental and fetal pulsatility indices in gestational diabetes mellitus. J Reprod Med 46:365-370, 2001
33. Saldeen P, Olofsson P, Laurini RN: Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 105:136-142, 2002
34. Teramo KA, Widness JA, Clemons GK, Voutilainen P, McKinlay S, Schwartz R: Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 69:710-716, 1987
35. Grosfeld A, Turban S, Andre J, Cauzac M, Challier JC, Hauguel-de Mouzon S, Guerre-Millo M: Transcriptional effect of hypoxia on placental leptin. FEBS Lett 502:122-126, 2001
36. Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A: Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 27:1187-1195, 2003
37. Arany E, Hill DJ: Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta 19:133-142, 1998
38. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D, Gregory M: Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab 80:2626-2632, 1995
39. Teasdale F: Histomorphometry of the placenta of the diabetic women: class A diabetes mellitus. Placenta 2:241-251, 1981
40. Babawale MO, Lovat S, Mayhew TM, Lammiman MJ, James DK, Leach L: Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature. Diabetologia 43:1185-1196, 2000
41. Jirkovska M, Kubinova L, Janacek J, Moravcova M, Krejci V, Karen P: Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res 39:268-278, 2002
42. Leach L, Mayhew TM: Vasculogenesis and angiogenesis in the diabetic placenta. In Diabetology of Pregnancy. Djelmis J, Desoye G, Ivanisevic M, Eds. Basel, Karger, 2005, p. 110-126
43. Rajala MW, Scherer PE: Minireview: the adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773, 2003
44. Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabete Metab 30:13-19, 2004
45. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P, Hauguel de Mouzon S: Maternal interleukin-6, a marker of fetal growth and adiposity. J Soc Gynecol Invest 13:53-57, 2005
46. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B: C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88:3507-3512, 2003
47. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N: Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 87:4231-4237, 2002
48. Hauguel de-Mouzon S, Guerre-Millo M: The placenta cytokine network and inflammatory signals. Placenta 27:794-798, 2005
49. Bowen JM, Chamley L, Mitchell MD, Keelan JA: Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 23:239-256, 2002
50. Hoegh M, Minium J, Bernard A, Varastehpour A, Catalano P, Hauguel de Mouzon S: Placental contribution to maternal adiponectin and resistin in late pregnancy. J Soc Gynecol Invest 12 (Suppl.):229A, 2005
51. Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, Vatish M, Randeva HS: Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49:1292-1302, 2006
52. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS: Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 139:327-335, 1991
53. Phillips TA, Ni J, Hunt JS: Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 22:663-672, 2001
54. Challier J, Galtier M, Bintein T, Cortez A, Lepercq J, Hauguel-de Mouzon S: Placental leptin receptor isoforms in normal and pathological pregnancies. Placenta 24:92-99, 2003
55. Kauma SW, Herman K, Wang Y, Walsh SW: Differential mRNA expression and production of interleukin-6 in placental trophoblast and villous core compartments. Am J Reprod Immunol 30:131-135, 1993
56. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitchell MD: Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 181:1530-1536, 1999
57. Lepercq J, Challier JC, Guerre-Millo M, Cauzac M, Vidal H, Hauguel-de Mouzon S: Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 86:2409-2413, 2001
58. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM: TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213, 2002
59. Malek A, Sager R, Schneider H: Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta 22 (Suppl. A):S45-S50, 2001
60. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, Hauguel-de Mouzon S: Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 47:847-850, 1998
61. Hauguel-de Mouzon S, Lepercq J, Catalano P: The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 194:1537-1545, 2006
62. Varastehpour A, Radaelli T, Minium J, Ortega H, Herrera E, Catalano P, Hauguel-de Mouzon S: Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity. J Clin Endocrinol Metab 91:248-255, 2005
63. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, Friedman JE: Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab 282:E522-E533, 2002
64. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE: Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 (Suppl. 2):S112-S119, 2007
65. Wolf M, Sauk J, Shah A, Vossen Smirnakis K, Jimenez-Kimble R, Ecker JL, Thadhani R: Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 27:21-27, 2004
66. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-De Mouzon S: Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49:1677-1685, 2006
67. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA: Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 83:341-347, 2004
68. Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I: Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 37:450-454, 2005
69. Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S, Garcia-Caballero T, Casanueva FF, Dieguez C: Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 90:4276-4286, 2005
70. Lappas M, Permezel M, Rice GE: Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 146:3334-3342, 2005
71. Zaretsky MV, Alexander JM, Byrd W, Bawdon RE: Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103:546-550, 2004
72. Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A: Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 106:802-807, 2005
73. Wolf HJ, Ebenbichler CF, Huter O, Bodner J, Lechleitner M, Foger B, Patsch JR, Desoye G: Fetal leptin and insulin levels only correlate in large-for-gestational-age infants. Eur J Endocrinol 142:623-629, 2000
74. Bouloumie A, Drexler HC, Lafontan M, Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059-1066, 1998